A novel AP-1/miR-101 regulatory feedback loop and its implication in the migration and invasion of hepatoma cells

Nucleic Acids Research

Volumn 42, Issue 19, 2014, Pages 12041-12051

  Liu, Jing Jing ^a   Lin, Xue Jia ^a   Yang, Xiao Jing ^a   Zhou, Liangji ^a   He, Shuai ^a   Zhuang, Shi Mei ^a   Yang, Jine ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MICRORNA 101; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN C FOS; TRANSCRIPTION FACTOR AP 1; MICRORNA; MIRN101 MICRORNA, HUMAN; MIRN101 MICRORNA, MOUSE;

3' UNTRANSLATED REGION; ANIMAL TISSUE; ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EMBRYO; FEEDBACK SYSTEM; GENE EXPRESSION; GENE LOCUS; GENETIC TRANSCRIPTION; HEPATOMA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; CELL MOTION; ENHANCER REGION; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; ENHANCER ELEMENTS, GENETIC; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; LIVER NEOPLASMS; MICE, INBRED C57BL; MICRORNAS; NEOPLASM INVASIVENESS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 84920278549     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku872     Document Type: Article

References (34)

1. Bartel, D.P. (2009) MicroRNAs: Target recognition and regulatory functions. Cell, 136, 215-233.
2. Ambros, V. (2004) The functions of animal microRNAs. Nature, 431, 350-355.
3. Di Leva, G., Garofalo, M. and Croce, C.M. (2013) MicroRNAs in cancer. Annu. Rev. Pathol., 9, 287-314.
4. Wang, H.J., Ruan, H.J., He, X.J., Ma, Y.Y., Jiang, X.T., Xia, Y.J., Ye, Z.Y. and Tao, H.Q. (2010) MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur. J. Cancer, 46, 2295-2303.
5. Varambally, S., Cao, Q., Mani, R.S., Shankar, S., Wang, X., Ateeq, B., Laxman, B., Cao, X., Jing, X., Ramnarayanan, K. et al. (2008) Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science, 322, 1695-1699.
6. Su, H., Yang, J.R., Xu, T., Huang, J., Xu, L., Yuan, Y. and Zhuang, S.M. (2009) MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res., 69, 1135-1142.
7. Strillacci, A., Valerii, M.C., Sansone, P., Caggiano, C., Sgromo, A., Vittori, L., Fiorentino, M., Poggioli, G., Rizzello, F., Campieri, M. et al. (2012) Loss of miR-101 expression promotes Wnt/beta-catenin signalling pathway activation and malignancy in colon cancer cells. J. Pathol., 229, 379-389.
8. Li, S., Fu, H., Wang, Y., Tie, Y., Xing, R., Zhu, J., Sun, Z., Wei, L. and Zheng, X. (2009) MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. Hepatology, 49, 1194-1202.
9. Cho, H.M., Jeon, H.S., Lee, S.Y., Jeong, K.J., Park, S.Y., Lee, H.Y., Lee, J.U., Kim, J.H., Kwon, S.J., Choi, E. et al. (2011) microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2. Exp. Ther. Med., 2, 963-967.
10. Kottakis, F., Polytarchou, C., Foltopoulou, P., Sanidas, I., Kampranis, S.C. and Tsichlis, P.N. (2011) FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathway. Mol. Cell, 43, 285-298.
11. Buechner, J., Tomte, E., Haug, B.H., Henriksen, J.R., Lokke, C., Flaegstad, T. and Einvik, C. (2011) Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogeneMYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma. Br. J. Cancer, 105, 296-303.
12. Pulverer, B.J., Kyriakis, J.M., Avruch, J., Nikolakaki, E. and Woodgett, J.R. (1991) Phosphorylation of c-jun mediated by MAP kinases. Nature, 353, 670-674.
13. Chen, R.H., Juo, P.C., Curran, T. and Blenis, J. (1996) Phosphorylation of c-Fos at the C-terminus enhances its transforming activity. Oncogene, 12, 1493-1502.
14. Shaul, Y.D. and Seger, R. (2007) The MEK/ERK cascade: From signaling specificity to diverse functions. Biochim. Biophys. Acta, 1773, 1213-1226.
15. Stapleton, G., Malliri, A. and Ozanne, B.W. (2002) Downregulated AP-1 activity is associated with inhibition of Protein-Kinase-C-dependent CD44 and ezrin localisation and upregulation of PKC theta in A431 cells. J. Cell Sci., 115, 2713-2724.
16. Ozanne, B.W., Spence, H.J., McGarry, L.C. and Hennigan, R.F. (2007) Transcription factors control invasion: AP-1 the first among equals. Oncogene, 26, 1-10.
17. Goffin, L., Seguin-Estevez, Q., Alvarez, M., Reith, W. and Chizzolini, C. (2010) Transcriptional regulation of matrix metalloproteinase-1 and collagen 1A2 explains the anti-fibrotic effect exerted by proteasome inhibition in human dermal fibroblasts. Arthritis Res. Ther., 12, R73.
18. Wisdom, R. (1999) AP-1: One switch for many signals. Exp. Cell Res., 253, 180-185.
19. Passegue, E., Jochum, W., Behrens, A., Ricci, R. and Wagner, E.F. (2002) JunB can substitute for Jun in mouse development and cell proliferation. Nat. Genet., 30, 158-166.
20. Lopez-Bergami, P., Lau, E. and Ronai, Z. (2010) Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat. Rev. Cancer, 10, 65-76.
21. Shalgi, R., Lieber, D., Oren, M. and Pilpel, Y. (2007) Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput. Biol., 3, e131.
22. O'Donnell, K.A., Wentzel, E.A., Zeller, K.I., Dang, C.V. and Mendell, J.T. (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 435, 839-843.
23. Martinez, N.J., Ow, M.C., Barrasa, M.I., Hammell, M., Sequerra, R., Doucette-Stamm, L., Roth, F.P., Ambros, V.R. and Walhout, A.J. (2008) A C. elegans genome-scale microRNA network contains composite feedback motifs with high flux capacity. Genes Dev., 22, 2535-2549.
24. Wang, L., Zhang, X., Jia, L.T., Hu, S.J., Zhao, J., Yang, J.D., Wen, W.H., Wang, Z., Wang, T., Zhao, J. et al. (2014) c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma. Hepatology, 59, 1850-1863.
25. Eferl, R. and Wagner, E.F. (2003) AP-1: A double-edged sword in tumorigenesis. Nat. Rev. Cancer, 3, 859-868.
26. Eferl, R., Ricci, R., Kenner, L., Zenz, R., David, J.P., Rath, M. and Wagner, E.F. (2003) Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell, 112, 181-192.
27. Reichmann, E., Schwarz, H., Deiner, E.M., Leitner, I., Eilers, M., Berger, J., Busslinger, M. and Beug, H. (1992) Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell, 71, 1103-1116.
28. Saez, E., Rutberg, S.E., Mueller, E., Oppenheim, H., Smoluk, J., Yuspa, S.H. and Spiegelman, B.M. (1995) c-fos is required for malignant progression of skin tumors. Cell, 82, 721-732.
29. Bartolazzi, A., Peach, R., Aruffo, A. and Stamenkovic, I. (1994) Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med., 180, 53-66.
30. Lamb, R.F., Hennigan, R.F., Turnbull, K., Katsanakis, K.D., MacKenzie, E.D., Birnie, G.D. and Ozanne, B.W. (1997) AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44. Mol. Cell. Biol., 17, 963-976.
31. Rohr-Udilova, N., Sieghart, W., Eferl, R., Stoiber, D., Bjorkhem-Bergman, L., Eriksson, L.C., Stolze, K., Hayden, H., Keppler, B., Sagmeister, S. et al. (2012) Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma. Hepatology, 55, 1112-1121.
32. Ming, J., Zhang, Q., Qiu, X. and Wang, E. (2009) Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: A mechanism of lymphangiogenesis in lung cancer. Eur. J. Cancer, 45, 866-873.
33. Mariani, O., Brennetot, C., Coindre, J.M., Gruel, N., Ganem, C., Delattre, O., Stern, M.H. and Aurias, A. (2007) JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas. Cancer Cell, 11, 361-374.
34. Lopez-Bergami, P., Huang, C., Goydos, J.S., Yip, D., Bar-Eli, M., Herlyn, M., Smalley, K.S., Mahale, A., Eroshkin, A., Aaronson, S. et al. (2007) Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell, 11, 447-460.